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Abstract
Genetic-epidemiological studies on monozygotic (MZ)
twins have been used for decades to tease out the
relative contributions of genes and the environment
to a trait. Phenotypic discordance in MZ twins has
traditionally been ascribed to non-shared
environmental factors acting after birth, however
recent data indicate that this explanation is far too
simple. In this paper, we review other reasons for
discordance, including differences in the in utero
environment, genetic mosaicism, and stochastic
factors, focusing particularly on epigenetic
discordance. Epigenetic differences are gaining
increasing recognition. Although it is clear that in
specific cases epigenetic alterations provide a causal
factor in disease etiology, the overall significance of
epigenetics in twin discordance remains unclear. It is
also challenging to determine the causality and
relative contributions of environmental, genetic, and
stochastic factors to epigenetic variability. Epigenomic
profiling studies have recently shed more light on the
dynamics of temporal methylation change and
methylome heritability, yet have not given a definite
answer regarding their relevance to disease, because
of limitations in establishing causality. Here, we
explore the subject of epigenetics as another
component in human phenotypic variability and its
links to disease focusing particularly on evidence from
MZ twin studies.
Keywords: Twins, Discordance, Epigenetics, Heritabil-
ity, Environment
Phenotypic variability and discordance
The extent to which phenotypic traits are heritable has
been a subject of scientific interest, at least since Galton’s
classic twin study design [1]. Twins offer a unique means
to study inheritance. Monozygotic (MZ) twins arise from
a single zygote, and have always been thought to inherit
identical genomic sequences [1], whereas dizygotic (DZ)
twins arise from two different zygotes and, just like sib-
lings, share on average 50% identity in their genomic
sequence. To assess the relative contribution of genes to
a trait, comparisons are made between MZ and DZ twin
concordance, with a greater MZ than DZ concordance
rate implicating a role for genetics in determining the
trait [1]. Phenotypic discordance between MZ twins has
traditionally been ascribed to non-shared environmental
exposures [2]; however, recent research highlights this as
being too simplified an explanation. In this review, we
focus on potential sources of MZ discordance.
In utero environment and discordance
There is a range of early environmental factors that need
to be considered as potential explanations for MZ twin
discordance. In some studies, similar pre-natal and post-
natal conditions, for example a shared in utero environ-
ment or upbringing in one family, have been thought to
promote phenotypic concordance, in contrast to non-
shared exposures [2,3]. However, the concept of non-
shared environment has important practical limitations. It
is difficult to unambiguously identify the distinct factors
and explain their differential effects on phenotype [3]. For
instance, although MZ twins share a single uterus in mul-
tifetal pregnancies, they do not necessarily share a com-
mon in utero environment. Twinning itself is thought to
be a rare malformation and a stochastic event, although
there exists evidence for familiality [1,4,5]. MZ twins occur
in about 3.5 in 1000 pregnancies or 4 in 1000 live births
[6,7]. Depending on the time of zygote splitting, MZ twins
can be divided into four groups[1]. If the zygote splits
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within 3 days, the twins are dichorionic and diamniotic
(DC DA) (18 to 36% of all MZ births). If splitting occurs
after the third but before the seventh day, the twins are
monochorionic but diamniotic (60 to 80% of cases) [1,8].
If division occurs between days 7 and 14, the twins are
monochorionic and monoamniotic (MC MA), which
accounts for 2 to 4% of all MZ twins[8]. Conjoined twins
arise when splitting happens after the days 13 or 14 [1,8].
All multifetal pregnancies are more prone to complica-
tions (such as fetal malnutrition, growth restriction, and
premature birth), with a mortality rate six times higher
than for singletons, and a shorter average duration of twin
pregnancy (35 weeks) [4,9-17]. Intrauterine growth restric-
tion (IUGR) is a common issue in twin pregnancies, affect-
ing 12 to 47% of all twin pairs [18]. It often leads to
discordance in birth weight [18-20], and has been linked
with discordance for a range of phenotypes, including
height, head circumference, intelligence, language compre-
hension and expression, fine motor performance, balance,
coordination, and visual-motor perception [18,20,21].
The potential causes of IUGR include genetic predispo-
sition, in utero crowding, uneven allocation of blastomeres,
uneven blood supply, and placental dysfunction (for exam-
ple, placental abruption, infarcts, stem vessel thrombosis,
velamentous insertion of the cord, and single umbilical
artery) [18,19,21-23]. Some of these events, such as
unequal division of blastomeres or uneven vascularization
of the placenta, can be considered as non-shared early
exposures, which can be classified, depending on the
adopted definition, as environmental or stochastic. IUGR
is even more pronounced in MC twins, for whom differ-
ences in placental sharing and vascularization lead to occa-
sional unequal blood and nutrient sharing, and, in about
15% of MC diamniotic pregnancies, result in twin-to-twin
transfusion syndrome (TTTS) [6,18,21]. MC twins have a
higher incidence of congenital heart disorders, and TTTS
increases this risk even further [6]. However, even in the
absence of TTTS, MC twins are seven times more likely
to develop congenital heart disease, and this usually occurs
in one twin only [5-7,13,21,24]. The higher risk nature of
multiple pregnancies, their proclivity towards complica-
tions, and the twin-twin competition for maternal
resources increases the probability of a skewed environ-
ment affecting the twins in utero [25,26].
After birth, any non-shared environmental exposure,
such as diet, smoking, toxin exposure and infection, may
contribute towards twin discordance [2,3,22,27-31].
Moreover, early phenotypic differences arising in twins
could potentially cause shared exposures to have different
effects, leading to dissimilarity between the twins.
De novo mutations and genetic mosaicism
It has been assumed that MZ twins are genetically iden-
tical, but a wealth of data are accumulating to show that
this is not necessarily the case. Mosaicism for de novo
mutations, retrotranspositions, indels, duplications, and
chromosomal rearrangements may play a role in MZ
twin discordance [32-44]. The rate for de novo base sub-
stitutions has been estimated at about 10-8 per base pair
per generation, making some genetic differences
between adult twins likely [45]. Postzygotic point muta-
tions have been found to be the source of MZ twin dis-
cordance in oral-facial-digital syndrome type 1, Joubert
syndrome, Van der Woude syndrome, Darier’s disease,
and neurofibromatosis type 1 while mosaicism for chro-
mosomal abnormalities has been implicated in discor-
dance for conditions such as Turner syndrome, trisomy
21, trisomy 13, skin pigmentation, and sex phenotypes
[46-51]. Postzygotic karyotypic mosaicism caused by
faulty mitotic division has also been reported in cases of
Ulrich-Turner syndrome [22].
Copy number variants (CNVs), which account for a
major portion of the genome, are strongly polymorphic
and relatively unstable, with mutation rates 100 to 10 000
times higher than those for single base substitutions[52].
Phenotypic discordance in MZ twins may in part be
caused by de novo mutations of CNVs and CNV mosai-
cism [32,34,36,53]. Indeed, it has been indicated that de
novo CNVs may occur at a rate of 10% per twinning
event; however, studies have so far failed to link CNV
mosaicism to any specific case of phenotypic discordance
in MZ twins [40,54-56].
Additionally, unequal exchange of cells during gesta-
tion might potentially lead to discordant fetomaternal
microchimerism [22].
Developmental noise and stochasticity
Some variation is inevitable as a result of transcriptional or
translational stochasticity, entailed by the random move-
ments of molecules and the complexity of their interac-
tions [57-63]. It should be expected that such noise can
lead to markedly different effects under identical environ-
mental conditions [64]. The effect of developmental
stochasticity might amass in a drift-like fashion, and thus
be more relevant to discordance in complex polygenic
traits such as height or weight, which develop over long
periods [58]. Stochastic events such as unequal division of
the inner mass cells during twinning, or unequal allocation
of the developmental markers or precursor cells to differ-
ent somatic lineages, have been reported as potential
sources of discordance in MZ twins [5,37]. Certain cases
of twin discordance might potentially be stochastic in ori-
gin, however because the causal mechanisms are not thor-
oughly understood, it is difficult to separate these from
environmental effects and gene-environment interactions.
Examples include discordance for eye or hair colour and
fingerprint profiles, cases of mirror twinning (affecting up
to 25% of MZ twins), and major malformations [22].
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Certain cases of differential allelic expression (DAE),
which result in random monoallelic gene expression,
arising as a result of X-inactivation or allelic exclusion in
olfactory and pheromone receptor genes, can constitute a
mechanism for stochastically driven phenotypic discor-
dance in MZ twins [22,65-70]. Although DAE has also
been estimated to affect about 50% of autosomal genes in
B-cells, the evidence from MZ twins indicates that the
overall degree of DAE is to a certain extent under genetic
control. with an estimated 30% of the affected genes
showing significant correlation between co-twins [71].
The precise estimates of DAE and its concordance in MZ
twins vary. A comprehensive whole genome expression
experiment conducted by Baranzini et al. indicated that
only 1.9% of heterozygous coding loci showed significant
evidence for DAE, but out of these, 57% were concordant
between the co-twins, still leaving room for stochastic
effects [72]; however, their findings were based on a sin-
gle MZ twin pair [72].
Epigenetics
Epigenetics was initially a term coined by developmental
biologists, and had no immediate link to the issues of
epidemiology and heredity [73,74]. Rather, the term
described the way in which gene-environment and gene-
gene interactions shape a phenotype during development.
The concept was developed as an argument for a complex
relation between genes and phenotype. Today, epigenetics
is used to describe alterations in genomic function, mainly
mitotically heritable changes in gene expression that occur
through chemical modifications to the structure of chro-
matin without altering the DNA sequence [2,27,73-76].
There is some limited evidence for transgenerational
inheritance of epigenetic changes in mammals, but the
scope and mechanisms are under study [3,77].
Cytosine methylation is one of the most well studied
epigenetic alterations found in vertebrates [27,73-76]. It
occurs at approximately 4 to 6% of the genomic cytosine
residues, depending on the cell type [78]. DNA methyla-
tion typically occurs in the context of CpG dinucleotides,
although this depends on cell type. In fetal fibroblasts,
99.98% of methylated cytosines are located in CpG dinu-
cleotides [78]. By contrast, for embryonic stem cells the
proportion reaches about 75%, which highlights the
importance of non-CG methylation for gene expression in
pluripotent stem cells. Cytosine methylation is mediated
by a family of proteins called DNA methyltransferases
[73,75,79]. This form of modification is generally asso-
ciated with transcriptional inactivation. It both physically
prevents transcription factors from binding to the DNA,
and can also recruit additional factors, such as methyl-
CpG binding domain proteins, which can promote repres-
sive histone modifications [27,73,75,76]. However some
CpGs remain unmethylated [73]. The precise mechanism
by which the differential methylation of CpG dinucleotides
occurs is unknown [73]. Recently, hydroxymethylation of
cytosines has been discovered, but its biological signifi-
cance is not yet known.
The second category of epigenetic modifications charac-
teristic of all eukaryotes is the category of covalent altera-
tions to histone proteins [27,73-76]. These affect the
N-terminal histone tails and, depending on the position
and the type of alteration, can either repress or promote
active chromatin conformation [73,76]. The two most
important types are acetylation and methylation [76]. The
various types of histone modifications have led to the
hypothesis of an epigenetic histone code that moderates
transcription in response to developmental cues and the
environment [76]. Cytosine methylation, histone modifica-
tions, and other types of chromatin remodeling all act
together in concert, and either reinforce or disable each
other through feedback loops [73].
There is substantial evidence in support of epigenetic
components in defining human phenotypic variation.
Most of this evidence comes from studies of defects in
genetic imprinting: an asymmetric, sex-dependent epige-
netic moderation of paternal versus maternal gene expres-
sion that manifests in monoallelic expression [75]. For
imprinted genes, epigenetic modifications are set anew in
the germline in each generation, according to sex [75].
Occasional abnormal cytosine methylation can result in
epigenetic alterations called epimutations, which just like
DNA mutations, can deactivate the gene or cause both
copies of the imprinted gene to be transcriptionally active
[75]. Such alterations can be divided broadly into three dif-
ferent categories, depending on their origin. Some epimu-
tations have a direct genetic cause, and are secondary to a
DNA mutation in cis or in trans; for instance mutations to
imprinting centers. Other epimutations are primary, with
no sequence alteration [75,80] (Figure 1). This latter cate-
gory can be further divided into stochastic epimutations,
caused by the inherently error-susceptible molecular
machinery, and environmental epimutations, which are
caused by environmental factors. This distinction can be
arbitrary because the environment can potentially cause
stochastic epimutations. The ratio between primary and
secondary epimutations is not well defined. There might
also exist an intermediate type of ‘facilitated epimutations’,
that is, when the likelihood of a stochastic epimutation at
certain locus is increased by genetic determinants[80].
Theoretically, any gene can be targeted by epimutation,
giving rise to abnormal conditions; however, imprinted
genes represent a more sensitive category on account of
their monoallelic expression.
If differences in DNA methylation can be sufficient to
cross the boundary between normal and disease pheno-
type in imprinted, monoallelically expressed genes, then it
is also probable that epimutations might affect expression
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of any pair of genes. Of course, with genes that are
expressed in a normal biallelic manner, the effects would
presumably be less severe. Consequently, as the complex-
ity and polygenicity of a trait increases, the effect of an epi-
mutation would most probably decrease. However, each
potential target for an epimutation would increase the
variability of that trait, and because epimutations may
arise during development, it follows that organisms can be
subject to epigenetic variegation and therefore ought to be
heterogeneous for their epigenomes [42,81]. Thus epige-
netic mosaicism between twins could be yet another
source of phenotypic variation. Indeed, mosaicism in epi-
genetic alterations has been described in MZ twins, and its
relevance to phenotype, particularly disease, is the subject
of current studies [82].
The significance of the environment and genes in driv-
ing epigenetic changes is a subject of debate, with some
authors claiming that epimutations might be stochastic in
nature and offer an alternative, non-heritable, and non-
environmental explanation for phenotypic variability
[2,72,73,83]. The key argument rests on the arbitrary
assumption that the random character of de novo faults in
DNA methylation, whose fidelity is estimated to be at the
level of 97 to 99.9% in cell culture, but lower in vivo, can-
not be ascribed to heritable genetic predispositions or to
the environment [2,73]. Thus, the concept of stochastic
epimutations as the third source of variation in opposition
to genetic and environmental effects has important limita-
tions because it is not evident that the random faults in
methylation maintenance are not themselves genetically
determined (in a similar way to DAE), or of environmental
origin.
Studies using methylome profiling, locally or globally,
offer a direct method of evaluating the specific contribu-
tion of epigenetics to a phenotype. Some of the main ques-
tions raised by these studies’ authors concern the nature of
this contribution, namely the ratio between hereditary,
environmentally triggered, and (potentially independent of
the former) stochastic changes. The extent of epigenetic
changes and epigenome heritability is disputable. A thor-
ough cross-sectional study of epigenetic profiles in the
lymphocytes of 80 MZ twins, aged between 3 and 74
years, revealed significantly greater discordance in the
older participants [29]. By estimating total genomic
5-methyl-cytosine content and histone H3 and H4 acetyla-
tion, 65% of the twins were found to have almost identical
epigenomes, while the remaining 35% were found to be
variably discordant. Both the histone acetylation and DNA
methylation profiles of twins become progressively discor-
dant with age, different lifestyles, and different medical
history. More importantly, the same pattern of epigenetic
discordance was seen with buccal epithelial cells, intra-
abdominal fat cells, and skeletal muscle cells. Fraga et al.
(2005) propose that the epigenome is strongly heritable at
birth, but epimutations arise and accumulate throughout a
lifetime, and their origin arises as a result of a combination
of external environmental factors and internal ‘epigenetic
drift’ arising from defects in methylation[29]. Although
such maintenance defects have been claimed by others to
represent ‘endogenous, stochastic mechanisms, indepen-
dent of environmental perturbations [84], Fraga et al. do
not exclude the notion they might be environmentally
triggered as well [29]. In a similar study, Kaminsky et al.
(2009) used CpG island microarrays to screen about 6000
loci (as compared with 1800 loci investigated by Fraga et
al.), in a cohort of 114 MZ and 80 DZ twins, in search of
methylation differences [85]. Some discordance was found
in white blood cells and replicated in buccal and gut tissue.
Estimates based on 20 MZ and 20 DZ pairs indicated that
methylation heritability was very low in white blood cells,
but rose in buccal tissue (findings based on 19 MZ and 20
DZ pairs), and was significantly greater when dichorionic
twins only were considered. The fact that the buccal
epithelial tissues of MC MZ twins were significantly more
discordant than those of DC twins signals chorionicity as
an important environmental factor influencing the epigen-
ome, and this was not taken into account in the study of
Fraga et al. The sample was not stratified according to
age, which precludes inferences regarding early discor-
dance. The findings of Kaminsky et al. (2009) may suggest
that late twinning can predispose to skewed environmental
conditions and to more discordant epigenetic profiles.
Kaminsky et al. oppose stochasticity to environmentally
Figure 1 (A) The mechanism of a secondary epimutation. A DNA
alteration at an imprinting center (IC) indirectly influences and alters
the methylation pattern (black and white triangles) at another locus,
which could be in cis or in trans. (B) In primary epimutation, the
external stimulus (whether environmental or stochastic) directly alters
the methylation.
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induced epigenetic differentiation, favoring the former
explanation as the more important in phenotypic discor-
dance of MZ twins [85].
The study of Fraga et al. (2005) stressed the signifi-
cance of age in DNA methylation discordance in twins.
The youngest twin pair studied by the authors had identi-
cal methylation levels [29]. In 2010, Saffery et al. sampled
four different tissue types from 56 MZ and 35 DZ twins
pairs at birth, and analysed them for CpG methylation at
four differentially methylated regions (DMRs) associated
with the IGF2/H19 locus [86]. Within the MZ pairs, the
absolute methylation difference for all DMRs and tissues
was generally small and ranged between 3 and 4%; how-
ever, the difference varied depending on the tissue type
and specific CpG tested. An effect of chorionicity was
confirmed. The largely similar epigenetic profiles at birth
would support the study of Fraga et al., but conclusions
are limited by the investigation of just four genetic
regions. Longitudinal studies of CpG methylation in MZ
twin cohorts, optimally sampled at birth first, are better
means to estimate the levels of epigenetic discordance
and make inferences upon its nature. In one of the first
longitudinal twin methylation studies, Wong et al.
attempted to address the issue of epigenetic heritability
and stochastic versus environmental epigenetic change
[87]. They examined 46 MZ and 45 DZ twin pairs for
methylation at three chosen loci relevant to psychology,
first at the age of 5 years and then at the age of 10 years.
They found variable discordance in all pairs. Not all loci
were equally prone to temporal epigenetic change,
although alterations were seen for all three genes. By
comparing MZ to DZ concordance rates, no significant
differences were detected, and the authors concluded
that alterations - both shared (indicated by high concor-
dance) and non-shared - were weakly heritable, and thus
predominantly attributable to the environment. Interest-
ingly, despite the low heritability, the intraclass correla-
tion coefficients (ICC) of MZ twins remained stable or
increased. This might be a consequence of the narrow
locus-specific scope of the study [87]. Wong et al. did
not give any explanation for the phenomenon and con-
cluded that the epigenome is dynamic and subject to
changes and environmental influence. It can differ
between MZ twins even in early childhood and, depend-
ing on the locus, both non-shared and common familial
environments can significantly affect its methylation pro-
file. However, Wong et al. acknowledge that when ICC
and heritability is low, indicating little familial environ-
ment and genetic contribution, stochastic epimutations
can provide an alternative explanation for the discor-
dance. Further confirmation of those conclusions are
required.
The most recent epigenomic study, by investigated
methylation levels in a cohort of 230 MZ twin pairs
(although 219 pairs appear in the analysis) whose age ran-
ged from 18 to 89 years, both globally and across a panel
of nine chosen loci that have been implicated in age-
related diseases and epigenetic regulation [88]. The
authors adopted a cross-sectional approach, but a subset
of 38 twins was re-assayed longitudinally after a 10-year
interval. Although a small intra-pair discordance for global
methylation was seen, older pairs were found to be twice
as discordant as the younger twins [88]. This trend also
held true for the disease-related loci, with older twins dis-
playing discordance that was 1.4 to 2.7-fold greater, and a
variation increasing proportionately with age (with very
weak effects of changing cellular heterogeneity) [88]. Both
global and locus-specific temporal increase in methylation
discordance was confirmed by a longitudinal follow-up.
The overall absolute global methylation differences
between the twins were nonetheless small (1.1% in
younger and 2.1% in older pairs). The results seem to con-
firm the earlier findings by Fraga et al. (2005) and suggest
that discordance increases progressively with age [88]. The
study points to the importance of unique individual envir-
onment behind the discordance, but explains the trend
with both the influence of stochastic and environmental
factors, acknowledging the difficulty in separating their
effects from each other, and stressing that non-shared
environmental exposures may also drive stochastic epige-
netic discordance [88]. Table 1 sums up the main methy-
lomic stability and discordance studies conducted in MZ
twins.
Together, these findings suggest that methylation pat-
terns can be to a large extent genetically determined and
heritable, yet do not remain stable over a person’s lifetime.
Variable degrees of epigenetic discordance can be seen in
MZ twins, and it is evident that sample size, age, tissue
type and CpG island selection can all significantly influ-
ence its estimates. There is substantial locus-to-locus and
inter-individual variation in temporal methylation
dynamics. To date, there is conflicting evidence on early
epigenetic discordance in MZ twins, but age should be a
crucial factor in all future studies of methylome changes.
Chorionicity seems to be an important factor altering dis-
cordance and heritability estimates, therefore studies
investigating methylome concordance in twins should also
take this into account, although this information is often
lacking. One potential problem that can affect findings in
longitudinal studies is resampling from epigenetically dif-
ferent cellular subpopulations [87]. The environmental
influence on the epigenome is relevant, and global epigen-
ome studies in human MZ twins alone cannot resolve the
sources of epigenetic discordance. Because the intrauterine
environment, post-natal shared and non-shared environ-
mental factors, and sequence polymorphisms acting in cis
and trans can all be partly responsible for the methylation
discordance, evaluating the significance of the intrinsic,
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stochastic epigenetic drift poses a methodological obstacle
that is difficult to surmount [4,29,73,86,87,89,90]. Estimat-
ing the exact proportion of stochastically determined dif-
ferences will require a deeper knowledge of the ways in
which the non-shared environment shapes the methylome
and the specific mechanisms responsible for the drift [29].
These may be difficult to investigate in humans.
Methylation studies and human disease
A number of studies have investigated methylation dif-
ferences in MZ twins in relation to disease or different
phenotypic conditions (Table 2). Initially, studies utilized
bisulfite conversion combined with sequencing of pre-
selected candidate loci. In some of the very first twin
methylation studies Petronis et al. found differences in
the CpG methylation of a regulatory sequence of the
dopamine D2 receptor, and this was greater in a schizo-
phrenia-discordant pair than in a concordant one [91].
Another early study using bisulfite sequencing found
methylation discordance at two regions of the COMT
gene promoter in a sample of six MZ twin pairs, all dis-
cordant for birth weight [92]. Oates et al. (2006) used
bisulfite sequencing of the AXIN1 promoter in a MZ
pair discordant for caudal duplication anomaly [93].
More recently, a survey of CpG methylation of six cho-
sen tumor-suppressor genes (ATM, BRCA1, BRCA2,
MLH1, RAD51C and TP53) in a single MZ twin pair
discordant for childhood leukemia and secondary thyr-
oid carcinoma, identified increased BRCA2 methylation
[82]. The proband had a significantly more methylated
promoter than the healthy co-twin. The main limitations
of these studies are the small sample sizes and narrow
scope, limiting the number of potential associations to
be found.
With the advance of microarray and next-generation
sequencing technology, it became possible to study
methylation changes on a genome-wide scale. In a study
of discordant risk-taking attitudes in a single MZ twin
pair, Kaminsky et al (2007) looked at CpG methylation
of about 12,192 CpG loci and found differences in
methylation of the DLX1 gene, implicated in stress-
response [94]. A methylation-sensitive-representational
difference analysis study on a MZ pair discordant for
bipolar disorder by Kuratomi et al. yielded four DMRs
and one candidate gene, also confirmed to be differen-
tially expressed [95]. Using an Illumina GoldenGate
array, Javierre et al (2009) looked at methylation of
1505 CpG sites in 807 gene promoters across five MZ
Table 1 Studies of CpG methylation discordance in monozygotic (MZ) twins
Study Type Method Tissue MZ pairs, n Conclusion
Fraga et
al. [29]
Cross-sectional,
age-stratified
High-performance capillary
electrophoresis of total methyl-
cytosine content
Peripheral lymphocytes;
buccal epithelial cells;
muscle biopsy; adipose
tissue
40 Young MZ twins are nearly identical
epigenetically; discordance
progresses with age, mediated by a
combination of external and/or
internal factors·
Kaminsky
et al. [85]
Cross-sectional Human 12 K CpG island
microarrays
White blood cells, buccal
epithelial cells, rectal biopsy
571 Methylation discordance in MZ twins
confirmed;· monochorionic MZ twins
significantly more discordant than
dichorionic MZ twins.. Epigenetic drift
suggested as the main cause of
discordance.
Saffery et
al. [86]
Cross-sectional,
taken at birth
Bis-seq (IGF2/H19) Cord blood, mononuclear
cells, buccal epithelial cells,
placental cells, umbilical
vein cells, endothelial cells
56 CpG methylation discordance can
arise in newborn twins by
combination of environmental and/or
stochastic factors acting in utero and
varies depending on the type of the
tissue.
Wong et
al. [87]
Longitudinal,
with single 5-
year interval
High-throughput mass
spectrometry (DRD4, SERT,
MAOA)
Buccal cells, epithelial cells 46 CpG methylation discordance is
present in early childhood and
susceptibility to epigenetic change is
highly locus-specific.. Environmental
influence is the main cause of
discordance, with various loci having
differential susceptibility to shared
and non-shared exposures.
Talens et
al. [88]
Cross-sectional
and
longitudinal
with single 10-
year interval
High-throughput mass
spectrometry; global methylation
and selected loci (IGF2, LEP, CRH,
ABCA1, INS, KCNQ1OT1, GNASAS)
Whole blood 230 Global and locus-specific methylation
increases gradually with age, owing
to unique environmental and
stochastic factors.
Abbreviations: MZ, monozygotic; Bis-seq, bisulfite sequencing
1Not all pairs were used for each estimate in the study
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twins discordant for systemic lupus erythematosus (SLE),
five twins discordant for rheumatoid arthritis (RA) and
five twins discordant for dermatomyositis (DM), and dis-
covered significant differences at 49 loci between the
SLE-affected twins and their healthy co-twins, which
were not seen in the RA and DM discordant twins [96].
The SLE cases had lower methylation levels and higher
expression in several genes with immune functions. In a
more recent analysis, Baranzini et al. used reduced repre-
sentation bisulfite sequencing to investigate differences in
methylation state of approximately 2 million CpG dinu-
cleotides in three MZ twin pairs discordant for multiple
sclerosis) [72]. The authors used high thresholds for
methylation differences, which reduced the number of
Table 2 Methylation studies in monozygotic (MZ) twins discordant for personality and disease
Study Condition Method Tissue MZ
pairs, n
Results
Weksberg
et al. [83]
Beckwith-
Wiedemann
syndrome
Southern blotting with
DMR probes (H19,
KvDMR1, SNRP)
Lymphocytes and
fibroblasts
10 Loss of methylation at KvDMR1 in all probands
Petronis
et al. [91]
Schizophrenia Bis-seq (DRD2) Lymphocytes 1 Discordance confirmed
Mill et al.
[92]
Attention deficit
hyperactivity
disorder
Bis-seq (COMT) Buccal epithelial cells 12 0.1 to 52.3% discordance
Oates et
al. [93]
Caudal duplication Bis-seq (AXIN1) PBMC 1 Discordance confirmed
Kuratomi
et al. [95]
Bipolar disorder MS-RDA Lymphoblastoid cell
lines
1 4 DMRs, 1 candidate gene
Kaminsky
et al. [94]
Risk-taking
behavior
MEDIP-chip PBMC 1 38 DMRs, 1 candidate gene
Mastroeni
et al. [32]
Alzheimer disease Immunohistochemistry Temporal neocortex 1 Discordance confirmed
Javierre
et al. [96]
Systemic lupus
erythematosus
MEDIP-chip White blood cells 5 49 DMRs, 8 candidate genes
Wong
et al. [87]
ADHD, depression,
antisocial behavior
Quantitative high-
throughput mass
spectrometry (DRD4, SERT,
MAOA)
Buccal epithelial cells 46 Discordance confirmed
Baranzini
et al. [72]
Multiple sclerosis RRBS CD4+ lymphocytes 3 2-178 DMRs, no candidate
Hu et al.
[98]
Autism MEDIP-chip Lymphoblastoid cell
lines
3 73 DMRs, 2 candidate genes
Tierling
et al. [118]
Beckwith-
Wiedemann
syndrome
Bis-seq (11 DMR) Peripheral blood cells,
buccal epithelial cells,
skin fibroblasts, saliva
1 Hypomethylation at KvDMR1
Harder
et al. [119]
Optic glioma Bis-seq (NF1) Leukocytes 8 Discordance confirmed
Souren
et al. [120]
BMI Bis-seq Saliva 8 Small discordance identified, not correlated with
BMI discordance
Rakyan
et al. [90]
Type 1 diabetes Illumina Array CD14+ cells 15 (+9
healthy
control)
132 methylation variable positions
Dempster
et al. [99]
Schizophrenia/
Bipolar disorder
Illumina Array Whole blood 22 Disease-associated DMRs, including ST6GALNAC1 as
the top candidate
Galetzka
et al. [82]
Childhood
leukemia/
secondary thyroid
carcinoma
Bis-seq (6 tumor
suppressors)
Skin fibroblasts 1 Increased BRCA1 methylation
Gervin
et al. [100]
Psoriasis Illumina Array CD4+ and CD8+ cells 27 No significant methylation difference. Significant
correlation between some DMRs and psoriasis-
associated gene expression differences
Abbreviations: Bis-seq, bisulfite sequencing; BMI, body mass index; DMR, differentially methylated region; MS-RDA, Methylation-sensitive representational
difference analysis; PBMC, peripheral blood mononuclear cell; RRBS, reduced representation bisulfite sequencing; MeDIP-chip, Methylated DNA
immunoprecipitation - chip
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differentially methylated loci to 2, 10 and 176 between
the different twin pairs. The differences were inconsistent
between the three twin pairs, leading the authors to con-
clude that methylation differences could not explain twin
discordance. The study’s small sample size and its hetero-
genous character (twins of Ashkenazi Jewish African
American and European descent) constituted perhaps the
greatest limitation reducing the power to detect signifi-
cant methylation differences [97]. A recent analysis of
methylation in three pairs of MZ twins discordant for
autism using an 8.1 K CpG microarray yielded 73 differ-
ently methylated CpG islands and two candidate genes
[98]. The first genome-wide study using an Illumina 27 k
array (covering ~27,000 CpG sites) of MZ twin methy-
lomes in schizophrenia and bipolar disorder in a cohort
of 22 discordant pairs revealed a number of disease-asso-
ciated DMRs, including GGN, SLC117A, SMUG1, SOX1
and TCF7L2, which had been implicated in a previous
study [99]. Methylome profiling with the Illumina 27 k
array in a MZ twin cohort discordant for psoriasis failed
to identify any significant DMRs, but did show that
methylation correlated with the levels of expression at
some disease-associated loci, including IL13, ALOX5AP,
PTHLH and TNFSF11 [100]. A slightly different
approach was adopted by Mastreoni et al., who used
immunohistochemistry to investigate whole-tissue
methylation [32]. Different methylation levels in temporal
neocortex neuronal nuclei were found in two MZ twins
discordant for Alzheimer disease, with hypomethylation
in the affected twin [32].
Although genome-wide studies have enabled discovery
of more DMRs, such studies are still in their infancy, and
face a number of issues [101]. To date, most studies have
investigated methylation in small samples of one to a
dozen twin pairs; use of larger discordant MZ twin
cohorts will increase the power to detect potentially cau-
sal DMRs. However, increasing the size of the twin sam-
ple might be challenging for rare diseases and study
designs involving longitudinal sampling [101]. Improve-
ments to study designs in the future will probably require
sampling from multiple tissues, particularly those that
might be relevant to disease, because variation in the epi-
genome varies significantly across different cell types,
and tissue-specific epimutations may play more impor-
tant roles than systemic epimutations. However, some
tissues are not easily accessible, and sampling from differ-
ent tissues might involve biopsy and post-mortem mate-
rial [101]. This is an important limitation, and some of
the recent studies assayed methylation differences in tis-
sues that were not directly relevant to the disease investi-
gated. Currently, the use of several technologies and
platforms makes crosscomparisons difficult [101,102].
Comparisons between MZ and DZ and between MC and
DC twins should provide insights into the role of genetics
and intrauterine environment in shaping epigenetic
variation.
Disease studies and causality
The associations yielded by various methylation studies
emphasize the need to develop methods that establish
causality [101,102]. Traditionally, in genetic studies, this
was achieved by demonstrating perfect co-segregation of
putative causal alleles with affected individuals in families,
as well as alterations to the expression or structure of the
protein encoded by the allele [103,104]. In non-mendelian
complex diseases with a significant environmental compo-
nent and no clear-cut disease segregation, causality is
mainly investigated through case-control association
studies by sorting candidate genes using P-value thresh-
olds that minimize false-positive errors, and optimally by
replicating the results in independent cohorts [105-107].
Of course, owing to linkage disequilibrium, population
stratification, type I and type II errors, or mere chance,
association does not equate to causality until proven by
functional work [106,108]. Proving causality is, just like
the definition, ultimately always context-dependent, and
there is no uniform agreement on what constitutes
adequate evidence; however, most authors are clear that
some physical, biological link ought to be established
[107,109-114]. Epigenetic alterations at promoter sites
should affect transcriptional activity [94,98]. However, the
problem is that epigenetic differences could in fact be
side-effects of disease or treatment. Studies investigating
epigenetic changes are potentially prone to false conclu-
sions as a result of reverse causation or confounding [115].
Because the nature of the epigenome is dynamic and most
epimutations arise throughout a person’s lifetime, the key
to addressing causality might be in their timing [97]. A
longitudinal approach assaying for epigenetic discordance
at birth or in early infancy and resampling at regular inter-
vals should produce a timeline for methylation changes,
and help to sort the potentially causal alterations from the
secondary, side-effect ones. Epigenetic differences identi-
fied in twins could be further investigated in longitudinal
cohorts as part of a two-stage study design [115].
Ultimately, studies of disease-associated epigenetic
changes should be followed up with the aim of establishing
a link with biological function [115]. To date, only one
longitudinal epigenome-wide study has been conducted,
investigating single CpG methylation differences in a panel
of MZ twins discordant for type 1 diabetes. [116] In this
study, 132 methylation variable positions associated with
disease status were discovered, some of which were repli-
cated in an independent group of nine singletons affected
with type 1 diabetes affected singletons prior to disease
diagnosis. [116]
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Conclusion
The plausible assumption made by Galton[117] that twin
discordance can be explained by differential environmental
exposures after birth is no longer tenable. Genetics, the in
utero environment, stochastity, and epigenetics can all
potentially play a role in determining phenotypic discor-
dance. The field of epigenetics is in its infancy. There is
very strong evidence for the direct role and relevance of
epigenetics in shaping human phenotypic variability. The
role of the epigenome can be both as a mediator of genetic
and environmental effects or as an independent stochastic
factor. Currently, the significance of primary epimutations
in twin discordance is unknown. Furthermore, it is not
fully clear as to what extent the epigenome is heritable
and whether monozygotic twins are epigenetically identi-
cal at birth. Further studies are required to address these
important questions. Ultimately, longitudinal studies with
repeated sampling may be required to fully understand the
nature of monozygotic twin discordance.
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